Infectious Diseases Newswire

Live Results

201 - Research and Markets: Morocco Pharmaceuticals and Healthcare Report - The Updated Q4 2009 Edition

DUBLIN-(Business Wire)-September 28, 2009 - Research and Markets is to be used to purchase protective masks. According to latest estimates, there have been 35 cases of swine flu in Morocco, of which 28 people have been released. Governments in the Maghreb region have responded in differing ways...

202 - Biomagnetics Diagnostics Receives a Financing Commitment up to $1 Million to Speed Development of Malaria Testing Technology

GENEVA-(Business Wire)-September 28, 2009 - Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced it has received a equity-based financing commitment up to $1 million...

203 - PolyMedix Receives U.S. Patent Protection for Licensed Computational Methods to Design Antimicrobial Polymers

RADNOR, Pa.-(Business Wire)-September 28, 2009 - PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for...

204 - Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA®, Seasonal Influenza Vaccine from CSL Biotherapies

WHITEHOUSE STATION, N.J.-(Business Wire)-September 28, 2009 - Merck & Co., Inc. announced today that the Company has entered into an exclusive agreement with CSL Biotherapies, a subsidiary of CSL Limited, to market and distribute AFLURIA® (Influenza Virus Vaccine), CSL's seasonal influenza...

205 - Helicos Announces System Sale to Correlagen Diagnostics

CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis. “We are very excited to have...

206 - Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies

CARLSBAD, Calif. & HEIDELBERG, Germany-(Business Wire)-September 28, 2009 - febit holding GmbH and Life Technologies Corporation (NASDAQ: LIFE) today announced that they have entered into a strategic co-marketing agreement to provide a new, scalable solution for researchers conducting targeted...

207 - Inovio Biomedical to Present at Vaccine 3rd Global Congress

SAN DIEGO-(Business Wire)-September 28, 2009 - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today it will make multiple presentations at the Vaccine 3rd Global Congress being held in Singapore October 4th – 6th. Inovio...

208 - Universal Detection Technology Receives Initial Purchase Order For Biological Weapon Detection Equipment

LOS ANGELES-(Business Wire)-September 28, 2009 - Universal Detection Technology , a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it...

209 - Swine Flu Vaccine Closer to Release

BALTIMORE-(Business Wire)-September 25, 2009 - The novel H1N1 virus (Swine Flu Virus) is expected to complicate the 2009/2010 flu season. The H1N1 vaccine has been approved for release but availability and access is still unknown. Seasonal influenza vaccine (flu shot) is available and the CDC...

210 - HealthSpring to Cover Administration Costs of H1N1 Vaccine

NASHVILLE, Tenn.-(Business Wire)-September 24, 2009 - HealthSpring will cover the costs of administering the H1N1 (swine) flu vaccination to its members as the vaccine becomes available. “We are fully supporting all government efforts for managing the H1N1 virus,” HealthSpring Chief Medical...

211 - Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting

CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that sustained virologic response (SVR) data from Study C208, which evaluated twice-daily dosing of Vertex’s investigational hepatitis C virus (HCV) protease inhibitor...

212 - Chao Center Donates Medications to Combat Multidrug-Resistant Tuberculosis

WEST LAFAYETTE, Ind.-(Business Wire)-September 24, 2009 - The Chao Center for Industrial Pharmacy & Contract Manufacturing officials announced that they will donate about 1,800 bottles of a medication to help fight multidrug-resistant tuberculosis (MDR-TB) to Cambodia and Ethiopia. The Chao...

213 - Priority Health to Cover Seasonal and H1N1 Flu Vaccines

GRAND RAPIDS, Mich.-(Business Wire)-September 24, 2009 - Priority Health has announced its coverage of both the seasonal flu and H1N1 flu vaccines. “Preventing the flu through immunization is the best way to keep yourself and your family healthy,” said John Fox, M.D., associate vice president of...

214 - Inhibitex Regains Compliance with NASDAQ Listing Requirements

ATLANTA-(Business Wire)-September 24, 2009 - Inhibitex, Inc. (Nasdaq: INHX) (the “Company”), a biopharmaceutical company focused on developing products to treat serious infectious diseases, announced today that it has received notice from The NASDAQ Stock Market ("Nasdaq") stating that, as the...

215 - GE Centricity EMR Helps Power Community Health Network’s Latest Innovation

BARRINGTON, Ill.-(Business Wire)-September 24, 2009 - GE Healthcare, a leading provider of healthcare information technology, is providing digital medical record technology for the Jane Pauley Community Health Center (Indianapolis). The center, which opened Wednesday, is a unique collaboration...

216 - Business Roundtable’s Partnership for Disaster Response to Announce Findings of 2009 Flu Season Survey

-(Business Wire)-September 24, 2009 - Business Roundtable:   WHAT: Business Roundtable, an association of CEOs of leading U.S. companies, will release the results of its 2009 Flu Season Survey, providing insight on how its member companies are preparing for H1N1 Influenza, the upcoming flu season...

217 - Integrated Environmental Technologies, Ltd. Announces EcaFlo® Anolyte (Excelyte®) Effective Against Swine Flu (H1N1)

LITTLE RIVER, S.C.-(Business Wire)-September 24, 2009 - Integrated Environmental Technologies, Ltd. (OTCBB: IEVM) announces the successful results of IET’s EcaFlo® Anolyte solution, marketed as Excelyte®, against Swine Influenza (H1N1). Specific testing performed by Microbiotest Labs of...

218 - Prime-Boost Vaccine Study Shows Modest Effect in Preventing HIV

SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 24, 2009 - Global Solutions for Infectious Diseases (“GSID”) announced today that a Phase III clinical trial of an investigational HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection. The...

219 - Inovio Biomedical CEO Addresses MIT’s Emerging Technologies Conference

SAN DIEGO-(Business Wire)-September 24, 2009 - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, Inovio’s CEO, presented keynote remarks at MIT’s Emerging Technologies Conference hosted by the...

220 - 17th Annual BioPartnering Europe™ and BioPartnering China™ Presents Innovative and Informative Program, Addressing Latest Trends Affecting the Biotech Industry Today

LONDON-(Business Wire)-September 24, 2009 - Technology Vision Group (TVG) is pleased to announce details of the program for the 17th Annual BioPartnering Europe (BPE) and BioPartnering China (BPC) conference in London from 11-14 October 2009, providing four days of networking in one location...

221 - Nanoviricides, Inc. CEO Dr. Eugene Seymour to Address the Livingston Healthcare and Life Science Stakeholders Summit

WEST HAVEN, Conn.-(Business Wire)-September 24, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that the Company’s CEO, Eugene Seymour, MD, MPH has been invited as a panelist at the 2nd Annual Livingston Healthcare Summit on September 24th, 2009 in New York City...

222 - Emergency Management & Safety Solutions Helps Individuals and Families Take Action to Prevent and Survive the Swine Flu

SAN FRANCISCO-(Business Wire)-September 24, 2009 - Emergency Management & Safety Solutions (EMS), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help people prepare for, prevent...

223 - Emergent Health Corp. (EMGE) Announces Pending Stock Split

KING OF PRUSSIA, Pa.-(Business Wire)-September 24, 2009 - Emergent Health Corp. (Other OTC: EMGE) Emergent expects to review a stock split to increase shares for each share currently owned by existing shareholders. The final decision for the actual split ratio is expected to be made by October 31...

224 - Research and Markets: Gilead Sciences: Pipeline - Products - Performance - Potential

DUBLIN-(Business Wire)-September 23, 2009 - Research and Markets OPERATIONAL DATA A wealth of background and detail A full 5-year financial performance assessment Key corporate events Key agreements Infrastructure Subsidiaries and joint ventures Companies Mentioned: 4AZA Bioscience Achillion...

225 - Walgreens to Compound Tamiflu Oral Suspension for Children in Response to Supply Shortage

DEERFIELD, Ill.-(Business Wire)-September 23, 2009 - Less than a month after launching the largest flu prevention initiative in the company’s 108-year history, Walgreens (NYSE: WAG)(NASDAQ: WAG) is taking proactive measures to ensure its nearly 7,000 pharmacies can provide the suspension - or...

226 - Blue Cross Blue Shield of Massachusetts Foundation Awards $1.25 Million to 11 Organizations Working to Reduce Health Care Disparities

BOSTON-(Business Wire)-September 23, 2009 - The Blue Cross Blue Shield of Massachusetts Foundation has awarded $1.25 million in grants to 11 community health organizations around the Commonwealth to address health care disparities on the basis of race, ethnicity, immigration status, age, mental...

227 - LifeSensors, Inc. Obtains Worldwide, Exclusive License to High Affinity “Ubiquitin Traps”

MALVERN, Pa.-(Business Wire)-September 23, 2009 - LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed...

228 - Focused Health Solutions Sponsors Educational Forum on Population Health Management

DEERFIELD, Ill.-(Business Wire)-September 23, 2009 - Focused Health Solutions, a leading national provider of customized population health management services, is hosting top healthcare industry experts in Chicago on Thursday, Oct. 15, for a timely discussion on population health management programs...

229 - Monongalia Health System Expands Premier Healthcare Alliance Affiliation to Include Web-Based Infection Tracking Solution

CHARLOTTE, N.C.-(Business Wire)-September 23, 2009 - Monongalia Health System of Morgantown, W.Va., is expanding its relationship with the Premier healthcare alliance by implementing Premier’s SafetySurveillor™ Web-based infection tracking and antimicrobial utilization solution. The health...

230 - Plexxikon Announces Encouraging Data from Phase 1 Extension Study of PLX4032 Showing Objective Responses in Metastatic Melanoma Patients

BERLIN, Germany & BERKELEY, Calif.-(Business Wire)-September 23, 2009 - Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032...

231 - AHF’s Blair Underwood HIV/AIDS Clinic to Open in DC Thursday Sept. 24th

WASHINGTON-(Business Wire)-September 23, 2009 - AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening...

232 - SuperGen to Present at UBS Life Sciences Conference at New Time of 8:30 am Eastern September 23rd

DUBLIN, Calif.-(Business Wire)-September 22, 2009 - SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, and Michael McCullar, Ph.D., Vice...

233 - Technology IV, Electronic Games II Feature Releases

SAN FRANCISCO-(Business Wire)-September 22, 2009 - The following releases focus on the topic Technology IV, Electronic Games II: ALL TIME-OFFS ARE IN EASTERN TIME, UNLESS NOTED STORIES MOVED AT 4:35 AM ET ON SEPTEMBER 22, 2009. CINCINNATI—Geek Speak on Campus Goes Beyond Co-Eds and Into...

234 - Top 20 Pharma Firms to Hunt for Deals at BIO-Europe 2009

ZURICH & VIENNA-(Business Wire)-September 22, 2009 - In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 2–4 in Vienna, Austria for BIO-Europe 2009, the largest dedicated partnering conference in Europe. Teams of scouts from...

235 - Axion Health and Comprehensive Health Services, Inc. (CHS) Partner to Deliver Pandemic Protection Program

DENVER-(Business Wire)-September 22, 2009 - Axion HealthTM (www.axionhealth.com), a workforce health protection, emergency preparedness and response provider, today announced that it will partner with Comprehensive Health Services, Inc. (www.chsmedical.com), the industry’s largest independent...

236 - HHS Secretary Sebelius and Education Secretary Duncan Announce Winner of 2009 H1N1 PSA Contest

WASHINGTON-(Business Wire)-September 22, 2009 - Department of Health and Human Services (HHS) Secretary Sebelius and Department of Education (ED) Secretary Arne Duncan today announced that Dr. John Clarke of Baldwin, N.Y., is the winner of the 2009 H1N1 PSA Contest. More than 50,000 votes were...

237 - Biomagnetics Enters into Agreement with One of China’s Largest Dairies

ORANGEVALE, Calif.-(Business Wire)-September 22, 2009 - Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has entered into an agreement with Bright Dairy, which...

238 - Quidel to Present at the William Blair & Company Emerging Growth Stock Conference

SAN DIEGO-(Business Wire)-September 22, 2009 - Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care diagnostic tests, today announced that it will present at the William Blair & Company 3rd Annual Emerging Growth Stock Conference to be held at the Waldorf-Astoria Hotel...

239 - Helicos Presents at Cold Spring Harbor Laboratories Personal Genomes and CHI Next Generation Sequencing Meetings

CAMBRIDGE, Mass.-(Business Wire)-September 22, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) provided updates on recent scientific findings and progress on Helicos’s technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation...

240 - Information Capture a Vital Link in Understanding, Tracking H1N1 Swine Flu

FULTON, Md.-(Business Wire)-September 22, 2009 - As health officials prepare to roll out millions of H1N1 swine flu vaccines this fall, many are contemplating whether to get the shot or risk coming down with the illness. Yet for officials at the state and local level, the question isn’t whether to...

241 - AIDS Healthcare Foundation’s First ‘AHF Blair Underwood Healthcare Center’ to Open in DC

WASHINGTON-(Business Wire)-September 21, 2009 - AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening...

242 - As Flu Season Approaches, LSA Prepares for a Potential Increase in Demand for Language Assistance with Business Continuity Plan

HORSHAM, Pa.-(Business Wire)-September 21, 2009 - LSA (Language Services Associates), a leading provider of premium language-based solutions, today announced its comprehensive business continuity plan (BCP) for the 2009-2010 flu season. The strategy, which was devised by LSA’s BCP project...

243 - Pfizer Commended For Leadership In Addressing Climate Change For Third Consecutive Year

NEW YORK-(Business Wire)-September 21, 2009 - Pfizer Inc has been commended by the Carbon Disclosure Project (CDP) for its approach to addressing climate change. CDP named Pfizer to its Climate Disclosure Leadership Index, which highlights the company’s climate change disclosure practices. This is...

244 - PeriGen, Inc. Taps Technology to Prevent and Treat H1N1 Influenza in Pregnant Women

PRINCETON, N.J.-(Business Wire)-September 21, 2009 - PeriGen, Inc., today announced the release of its Influenza Prevention and Treatment Bundle to its North American client hospitals. In advance of the approaching flu season, PeriGen’s protocol bundle will help clinicians follow recommended...

245 - Advaxis Granted New Compositions and Methods Patent

NORTH BRUNSWICK, N.J.-(Business Wire)-September 21, 2009 - The United States Patent and Trademark Office (USPTO) has granted and issued Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, patent 7,588,930 “Compositions and Methods for Enhancing...

246 - BioForward Announces Winners of Biotechnology Vision Summit’s Emerging Company Showcase

MADISON, Wis.-(Business Wire)-September 21, 2009 - Six Wisconsin biotechnology companies have been selected the winners of the first Emerging Company Showcase. The showcase is part of the Biotechnology Vision Summit 2009, being held on Wednesday, Oct. 7, at the Madison Marriott West in Madison, Wis...

247 - Antigenics Announces Expansion of Its QS-21 License Agreement

LEXINGTON, Mass.-(Business Wire)-September 21, 2009 - Antigenics Inc. (NASDAQ: AGEN) today announced that the company has signed an amended and restated license agreement for the use of the QS-21 adjuvant in a vaccine under development by JANSSEN Alzheimer Immunotherapy, a company which has acquired...

248 - Cannabis Science Updates Progress For Its Phytocannabinoid Pharmaceutical Products To Help Reduce ARDS-Associated Deaths From Both The Avian And Swine Influenza Infections

COLORADO SPRINGS, Colo.-(Business Wire)-September 21, 2009 - Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report progress for its phytocannabinoid pharmaceutical products to help reduce ARDS-associated deaths from both the Avian and Swine...

249 - Sloning Closes Growth Financing Round Led by LBBW Venture

PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...

250 - VeriChip Corporation Granted Exclusive License for Patents Used in Virus Triage Detection System for H1N1 Virus

DELRAY BEACH, Fla. & CHASKA, Minn.-(Business Wire)-September 21, 2009 - VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding...

251 - Research and Markets: Evidence-Based Infectious Diseases, 2nd Edition

DUBLIN-(Business Wire)-September 21, 2009 - Research and Markets . Hepatitis. Influenza pandemic. Critical care. Part 2: Special populations. Infection control. Infections in neutropenic hosts. Infections in general surgery. Infections in the thermally injured patient. Infections in healthcare...

252 - PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference in Boston, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of the Columbus™ 2.0 platform, its flagship high content...

253 - Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo’s Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis

NEW YORK-(Business Wire)-September 21, 2009 - Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel...

254 - Pacific Biosciences Expands Mission and Prepares for Commercialization

MENLO PARK, Calif.-(Business Wire)-September 21, 2009 - Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today provided a number of updates to its commercial strategy and progress. First...

255 - National Institute of Allergy and Infectious Diseases to Give Update On NIAID-Supported Clinical Trials of 2009 H1N1 Influenza Vaccines in Children Six Months to 17 Years of Age

-(Business Wire)-September 21, 2009 - HHS Media Advisory: WHAT: Anthony S. Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases, will give an update on NIAID-supported clinical trials of 2009 H1N1 influenza vaccines in children six months to 17 years of age.   Jesse...

256 - NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies

WEST HAVEN, Conn.-(Business Wire)-September 21, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that it has signed a “Master Service Agreement” with the Southern Research Institute (“Southern Research”), Birmingham, AL. Southern Research is a well established...

257 - Most Americans Lacking Direction from Their Employers for the H1N1 Flu Season, Survey Shows

NEW YORK-(Business Wire)-September 21, 2009 - Most workers have not had any direction from their employers about the upcoming flu season, according to a national survey released today by Mansfield Communications Inc. In the survey of a national representative sample, 69 per cent of respondents say...

258 - Reportlinker Adds Bristol-Myers Squibb Co.: PharmaVitae Profile

NEW YORK-(Business Wire)-September 21, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Bristol-Myers Squibb Co.: PharmaVitae Profile...

259 - Quidel Issues Clarification Regarding Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert

SAN DIEGO-(Business Wire)-September 18, 2009 - Quidel Corporation (NASDAQ: QDEL), a global leader in point-of-care (POC) rapid diagnostic tests, issues clarification regarding the Special 510(k) clearance for an update to the Company's QuickVue® Influenza A+B test package insert. A news wire agency...

260 - Experts Available to Discuss: Swine Flu Might Be Even More Contagious; Tests Show People 'Shed' the Swine Flu Virus for Days Longer Than First Thought

-(Business Wire)-September 18, 2009 - ExpertSource: TOPIC: ABC News and other outlets are reporting that two studies released on Tuesday suggest that people infected with the H1N1 virus continue to shed virus after the point where current recommendations say they can resume their normal...

261 - Metabasis Therapeutics Receives Notice of Noncompliance with Nasdaq Listing Requirements

SAN DIEGO-(Business Wire)-September 18, 2009 - Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”), notifying the Company that based upon the closing...

262 - Research and Markets: Infectious Disease - Clinical Cases Uncovered Gives the Know-How to Recognize, Understand, Investigate and Manage Many Infectious Conditions

DUBLIN-(Business Wire)-September 18, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Infectious Disease: Clinical Cases Uncovered" to their offering. Infectious Disease is a core topic within the clinical curriculum and students are expected to...

263 - Top Global Health Experts to Report Innovative Technologies in Pipeline That Will Change Health Conditions for the World’s Poor

-(Business Wire)-September 18, 2009 - New ideas, systems and technologies are emerging to solve numerous health challenges facing the world’s poorest communities. Some of the foremost experts on global health will discuss these and the prospects for health breakthroughs in the developing world...

264 - Vertex Pharmaceuticals Announces Webcast of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass.-(Business Wire)-September 18, 2009 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the UBS Global Life Sciences Conference on Tuesday, September 22, 2009 at 2:30 p.m. EDT and at the JMP Securities Healthcare Conference...

265 - Know What to Do About the Flu Webcast for Small Businesses Live on Flu.gov

WASHINGTON-(Business Wire)-September 17, 2009 - The U.S. Department of Health & Human Services will co-host a Know What to Do About the Flu Webcast FRIDAY September 18th. Top experts from the U.S. Dept. of Homeland Security, Centers for Disease Control & Prevention, U.S. Small Business...

266 - Universal Detection Technology Addresses Bioterrorism Threat to National Security at ASIS 2009

LOS ANGELES-(Business Wire)-September 17, 2009 - Universal Detection Technology (www.udetection.com)(OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today...

267 - Hythiam Raises Approximately $7 Million in Registered Direct Offering

LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing...

268 - Meridian Bioscience Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU® Test Package Insert

CINCINNATI-(Business Wire)-September 17, 2009 - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the company has been granted a Special 510(k) clearance to update the TRU FLU package insert to include analytical sensitivity claims with two strains of 2009 H1N1 virus...

269 - EKR Therapeutics to Present at the 2009 UBS Global Life Sciences Conference

BEDMINSTER, N.J.-(Business Wire)-September 17, 2009 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing critical-care products for the hospital setting, today announced that Howard Weisman, CEO & President, will present at the UBS Global Life Sciences...

270 - Enzo Biochem’s Life Sciences Unit Introduces Novel System for Simultaneous Live-Cell Imaging of Nuclear Components

FARMINGDALE, N.Y.-(Business Wire)-September 17, 2009 - Enzo Life Sciences, a division of Enzo Biochem, Inc. (NYSE:ENZ), has added a novel new system to its CELLestial™ line of live cell analysis products, providing expanded capability to simultaneously image both the nucleus and the nucleolus in...

271 - Navigenics Welcomes Michael Critelli to Board of Directors

FOSTER CITY, Calif.-(Business Wire)-September 17, 2009 - Navigenics, a leading personal genomics testing company, announced today that Michael J. Critelli has been appointed to its board of directors. Upon his retirement in February 2009, Mr. Critelli completed a nearly 30-year career at Pitney...

272 - Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing

BURLINGAME, Calif.-(Business Wire)-September 17, 2009 - Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, announced that it has completed the first close on its Series B equity financing of up to $25 million led by SV Life Sciences...

273 - Quidel Obtains Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert

SAN DIEGO-(Business Wire)-September 17, 2009 - Quidel Corporation (NASDAQ: QDEL), a global leader in point-of-care (POC) rapid diagnostic tests, received Special 510(k) clearance for an update to the Company's QuickVue® Influenza A+B test package insert to include reactivity with culture isolates...

274 - Merial Licenses Scarab Genomics’ Clean Genome® E. coli for Commercial Production of New Animal Vaccine.

MADISON, Wis.-(Business Wire)-September 17, 2009 - Merial, a world leading animal health company, has licensed the Clean Genome E. coli developed by Scarab Genomics, LLC, a Madison, WI biotechnology company, for commercial production of an upcoming veterinary vaccine. Clean Genome E. coli are K-12...

275 - Wellcome Trust and Merck Launch First of Its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries

LONDON & WHITEHOUSE STATION, N.J.-(Business Wire)-September 17, 2009 - The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a...

276 - Positive Phase IIb Results for GSK1838262 (XP13512) Reported for Neuropathic Pain Associated with Post-Herpetic Neuralgia

RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.-(Business Wire)-September 17, 2009 - GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for...

277 - EBD Group and Defined Health Form an Alliance on Conference Content

CARLSBAD, Calif. & ZURICH, Switzerland & FLORHAM PARK, N.J.-(Business Wire)-September 16, 2009 - EBD Group and Defined Health today announced the formation of an alliance that will help biopharmaceutical firms gain the insights they need to create and execute successful strategy. Under...

278 - Premera Eliminates Member Costs for H1N1 Vaccine

MOUNTLAKE TERRACE, Wash.-(Business Wire)-September 16, 2009 - Premera Blue Cross today announced actions to provide peace of mind to its members in underwritten plans by waiving member cost-sharing, including applicable co-pays and deductibles, associated with the H1N1 vaccine. “Premera has been...

279 - Clear Channel Radio to Program WADV as News/Talk Station for Advertising Week 2009

WHAT:   The official radio station of Advertising Week 2009.   WHO: The biggest names in advertising and marketing. Powered by iheartradio.   WHY: A fully produced news/talk station focused on all things advertising. Interviews with industry and marketing leaders interspersed with news reports on...

280 - Internationally Acclaimed Inventor, Dean Kamen, to Receive Prestigious BioMed SA Palmaz Award for Innovation in Healthcare and the Biosciences

SAN ANTONIO-(Business Wire)-September 16, 2009 - Internationally renowned inventor, entrepreneur and thought leader, Dean Kamen of Manchester, NH, can add another prestigious award to his resume when he accepts BioMed SA’s Julio Palmaz Award for Innovation in Healthcare and the Biosciences. BioMed...

281 - Walgreens Reaches One Million Seasonal Flu Shots as Consumer Awareness Drives Record Pace for Immunizations

DEERFIELD, Ill.-(Business Wire)-September 16, 2009 - Following two weeks of unprecedented consumer demand for seasonal flu shots, Walgreens (NYSE:WAG)(NASDAQ:WAG) has administered more than one million immunizations since it began offering them Sept. 1 at its 7,000 drugstores nationwide and nearly...

282 - Biomagnetics Continues Contract Talks With U.S. Government’s Premier National Security Research Institution

ORANGEVALE, Calif.-(Business Wire)-September 16, 2009 - Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is in continuing contract negotiations to...

283 - VeriChip Corporation to Fund Development Partnership with RECEPTORS LLC to Market New Triage Detection System for H1N1 Virus

DELRAY BEACH, Fla.& CHASKA, Minn.-(Business Wire)-September 16, 2009 - VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding...

284 - Helicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private Placement

CAMBRIDGE, Mass.-(Business Wire)-September 16, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement...

285 - Cyntellect Launches Stem Cell Manager™ Powered by LEAP™

SAN DIEGO-(Business Wire)-September 16, 2009 - Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, announced today the commercial availability of Stem Cell Manager...

286 - AVANIR to Present at the UBS Global Life Sciences Conference

ALISO VIEJO, Calif.-(Business Wire)-September 16, 2009 - AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced that the Company will present at the UBS Global Life Sciences Conference on Wednesday, September 23rd at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) at the Grand Hyatt New York...

287 - Oculus Innovative Sciences Announces New Partnership Agreement with V&M Industries, Inc. for Microcyn®-Based OTC Human Wound Care Products

PETALUMA, Calif.-(Business Wire)-September 16, 2009 - Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to treat infections in chronic and acute...

288 - Baxter Hosts 2009 Investor Conference

CHICAGO-(Business Wire)-September 16, 2009 - At its Investor Conference today in Chicago, Baxter International Inc. (NYSE:BAX) will discuss its long-range financial objectives, growth opportunities and various research and development programs that highlight the company’s focus on innovation and...

289 - PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets

WALTHAM, Mass.-(Business Wire)-September 16, 2009 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay...

290 - Progenics Announces Promotion of Mark R. Baker to President and Appoints Him to Board of Directors

TARRYTOWN, N.Y.-(Business Wire)-September 16, 2009 - Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the promotion of Mark R. Baker to the newly created position of President. Mr. Baker was also appointed to the Board of Directors. He will continue to report to Paul J. Maddon, M.D...

291 - Inovio Biomedical CEO to Present at MIT Technology Review Emerging Technology Conference

SAN DIEGO-(Business Wire)-September 16, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, CEO, has been invited to present at EmTech, the Emerging Technologies Conference hosted by MIT and...

292 - Washington State Life Sciences Discovery Fund Awards Health Research Project Grants

SEATTLE-(Business Wire)-September 15, 2009 - Six research project grant awards totaling $5.1 million will be made to Washington life sciences organizations and their partners, the state’s Life Sciences Discovery Fund announced today. The projects are aimed at improving human health and will...

293 - Cub Pharmacies Begin Giving Flu Shots Wednesday, September 16

-(Business Wire)-September 15, 2009 - Cub Foods: WHAT:     Seasonal flu shots are starting earlier this season. While flu season typically begins October 1, there is a great deal of concern about seasonal flu and H1N1 (swine flu).         WHO: Cub Pharmacist Doug White administers flu shots...

294 - Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2010 and Reaffirms Fiscal 2009 Guidance

CINCINNATI-(Business Wire)-September 15, 2009 - Meridian Bioscience, Inc. (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2010 sales and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year...

295 - US Expert Bill Marler Urges UK Adoption of US Petting Zoo Guidelines to Prevent E. coli Outbreaks

SURREY, England-(Business Wire)-September 15, 2009 - News that a large and growing outbreak of highly toxic E. coli O157:H7 linked to the Gladstone Farm and Playbarn in Surrey, England has led E. coli expert Bill Marler to urge animal exhibitors on both sides of the Atlantic to implement existing...

296 - Business Leaders See Need to Fast-Track H1N1 Preparedness

MINNEAPOLIS-(Business Wire)-September 15, 2009 - Business and healthcare leaders looking to fast-track preparedness for the H1N1 pandemic are gathering with infectious disease experts and Fortune 500 planners this month to determine how best to protect their employees and preserve their...

297 - Nation’s Fifth Largest County Implements LiveProcess, the Leading Emergency Management Platform for Healthcare

VERONA, N.J.-(Business Wire)-September 15, 2009 - LiveProcess, the market leader in web-based emergency preparedness and incident management solutions for healthcare, announced today the implementation of its centralized, disaster preparation and response system in the 32 hospitals of Orange County...

298 - Nomir Medical Announces Publication of Mechanism-of-Action Data for its Noveon® Dual-Wavelength Device

WALTHAM, Mass.-(Business Wire)-September 15, 2009 - Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today the publication of a scientific paper in the journal Photochemistry and Photobiology that details in vitro and human...

299 - LEAD Therapeutics Presents New Antibiotic With Potent Activity Against Drug Resistant Bacteria at the 49th ICAAC

SAN BRUNO, Calif. & SHANGHAI-(Business Wire)-September 15, 2009 - LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria. LEAD will present the new glycopeptide...

300 - Primary Care Doctors Are the Critical Navigators for Patients During the Upcoming Flu Season

BOCA RATON, Fla.-(Business Wire)-September 15, 2009 - The news about the H1N1 flu has been non-stop. And the prediction that up to 50% of Americans will get the flu is frightening. So what should you do to protect yourself? Dr. Bernard Kaminetsky, the medical director of MDVIP, a national network of...

301 - Talecris Commences Initial Public Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 15, 2009 - Talecris Biotherapeutics Holdings Corp. (“Talecris”) today announced the launch of its initial public offering of 44,736,842 shares of its common stock, par value $0.01 per share. Talecris is a global biotherapeutic and...

302 - Diagnostic HYBRIDS Announces FDA Clearance of D3® FastPointTM L-DFATM Respiratory Virus Identification Kit

ATHENS, Ohio-(Business Wire)-September 14, 2009 - Diagnostic HYBRIDS, a leading developer of IVD fluorescent staining kits and cell culture products, today announced the U.S. Food and Drug Administration (FDA) (510k) clearance of its D3 FastPointTM L-DFATM Respiratory Virus Identification Kit, which...

303 - Spanish and English Webinars on Keeping Restaurants Healthy During Flu Season Offered by National Restaurant Association and Ecolab

ST. PAUL, Minn.-(Business Wire)-September 14, 2009 - Ecolab Inc. and the National Restaurant Association today announced that they will partner to present two webinars this week – one in English and one in Spanish – to help restaurant owners and operators protect their guests – and...

304 - SBA Administrator Announces Availability of H1N1 Preparedness Guide for Small Businesses

WASHINGTON-(Business Wire)-September 14, 2009 - Small Business Administration Administrator Karen Mills and Department of Homeland Security Secretary Janet Napolitano today announced the availability of a preparedness guide designed to assist small businesses in planning for the possibility of an...

305 - Kids Hand Sanitizer Arrives Just in Time for Cold and Flu Season

CHICAGO-(Business Wire)-September 14, 2009 - With health officials nationwide already preparing for the upcoming cold and flu season, Environmental Solutions International (ESI) introduces Smart & Silky and Kids Smart & Silky Foaming Hand Sanitizers as another weapon in the...

306 - Achaogen Announces ACHN-490 Clinical Data at the 49th Annual ICAAC Meeting

SAN FRANCISCO-(Business Wire)-September 14, 2009 - Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative, broad-spectrum antibiotics, today announced the results of a Phase 1 trial...

307 - NanoViricides Platform Enables Rapid Development of Robust Nanomedicines Against Influenza and HIV

WEST HAVEN, Conn.-(Business Wire)-September 14, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company presented a talk at NanoBusiness 2009 - the 8th annual NanoBusiness Conference in Chicago, IL, on Wednesday, September 9th. Dr...

308 - Biomagnetics Diagnostics Corp. Retains Emerging Growth Research, LLP for Public and Investor Relations

ORANGEVALE, Calif.-(Business Wire)-September 14, 2009 - Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public...

309 - PolyMedix to Make Three Presentations of Antibiotic Data at the 49Th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

RADNOR, Pa.-(Business Wire)-September 14, 2009 - PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will make three presentations of clinical and...

310 - Thermo Fisher Scientific Features Innovative Food Safety Solutions at AOAC 2009

PHILADELPHIA-(Business Wire)-September 14, 2009 - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is featuring its industry-leading range of instrumentation, equipment, consumables and software used for food safety testing at the AOAC...

311 - Dry Hands Are 1,000 Times Safer Than Damp Hands

PHILADELPHIA-(Business Wire)-September 14, 2009 - Countries around the world are trying to tackle the escalating H1N1 (swine flu) pandemic in different ways. Advice from all authorities, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), remains...

312 - Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate

NEEDHAM, Mass.-(Business Wire)-September 14, 2009 - Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the first patient has been dosed in a Phase 1/2 study of its vaccine candidate, CDX-1401, in patients with malignant solid tumors that express NY-ESO-1. CDX-1401 is a fully human...

313 - Aradigm Presents Data Demonstrating Significant Antibacterial Concentrations and Effects in Non-Cystic Fibrosis Bronchiectasis Patients Following Administration of its Once-Daily Inhaled Liposomal Ciprofloxacin

HAYWARD, Calif.-(Business Wire)-September 14, 2009 - Aradigm Corporation (OTCBB: ARDM) ("Aradigm") today announced it is presenting data from its Phase 1 and Phase 2a studies at the ERS Annual Congress in Vienna, Austria, September 12-16, 2009. The first presentation describes the significant...

314 - Variation Biotechnologies Flu Vaccine Provides Robust Immune Response, Broad Protection against H1N1 Influenza Strain

CAMBRIDGE, Mass.-(Business Wire)-September 14, 2009 - Variation Biotechnologies, Inc. (VBI), an emerging leader in the discovery and development of novel vaccines to fight infectious diseases, today reported that the company’s proprietary influenza vaccine triggered a robust immune response and...

315 - Napolitano, SBA Administrator Mills and Experts from the Centers for Disease Control and Prevention to Announce H1N1 Guidance for Small Businesses

WASHINGTON-(Business Wire)-September 11, 2009 - U.S. Secretary of Homeland Security Janet Napolitano, Karen Mills, Administrator, U.S. Small Business Administration, Dr. Daniel Jernigan, Deputy Director, Influenza Division, Centers for Disease Control & Prevention will hold a conference call...

316 - Statement by Dr. Anthony Fauci, Director, National Institute of Allergy and Infections Diseases, NIH, Regarding Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults

WASHINGTON-(Business Wire)-September 11, 2009 - We are encouraged by reports that are now emerging from various clinical trials of 2009 H1N1 influenza vaccines, conducted by various vaccine manufacturers. We expect additional companies to announce their preliminary trial results shortly. The early...

317 - The Children’s Hospital Influenza Experts Provide Information and Tips Related to H1N1 and Seasonal Flu in Children

DENVER-(Business Wire)-September 11, 2009 - With the early onset of flu season coinciding with the start of school this year, concern about the flu, and in particular the H1N1 strain of the flu, is growing among parents. Experts from The Children’s Hospital in Denver, Colo., can offer a...

318 - Mortuary Response Solutions Develops Portable Mass Fatality Remains Storage Systems

BELTON, S.C.-(Business Wire)-September 11, 2009 - Healthcare professionals expect a significant surge in H1N1 influenza cases during the fast-approaching flu season. More than half of the United States population could ultimately be infected, with deaths expected to reach, or quite possibly...

319 - Weekly Media Briefing on 2009 H1N1 Flu Friday, September 11 at 1:00 p.m. at HHS

-(Business Wire)-September 11, 2009 - The Department of Health and Human Services will host the weekly H1N1 press briefing this Friday, September 11, in Washington, D.C. Top scientists and doctors from the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and...

320 - Research and Markets: Disease and Therapy Review: a Comprehensive Overview of HIV/AIDS and Related Conditions

DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets III. Diagnosis And Treatment Diagnostic Tests Antiretroviral Treatments IV. Dosing And Treatment Costs V. Market Size VI. Comments VII. References/Resources For more information visit...

321 - BioNeutral Announces Ability of Ygiene® To Deliver A Rapid and Total Kill of The Swine Flu (H1N1) Virus at 1:10 Dilution

NEWARK, N.J.-(Business Wire)-September 11, 2009 - BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced today that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia, demonstrated that Ygiene...

322 - Teva Announces Presentations at Bank Conferences

JERUSALEM-(Business Wire)-September 11, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Morgan Stanley Global Healthcare Conference in New York with William Marth, President and Chief Executive Officer, Teva North America presenting on Monday...

323 - Fewer Injection Site Reactions in Patients Using AVONEX® Versus Sub-cutaneous Interferon and Glatiramer Acetate for the Treatment of Multiple Sclerosis

CAMBRIDGE, Mass.-(Business Wire)-September 11, 2009 - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to...

324 - Variation Biotechnologies to Present Positive Influenza Vaccine Data at the 49th Annual ICAAC Meeting

CAMBRIDGE, Mass.-(Business Wire)-September 11, 2009 - Variation Biotechnologies, Inc. (VBI), an emerging leader in the discovery and development of novel vaccines to fight infectious diseases, today announced that it plans to present positive results from a preclinical study of the company’s...

325 - New WHO Data Underscores Global Threat of the World’s Leading Child Killer

WASHINGTON-(Business Wire)-September 11, 2009 - New World Health Organization data to be published in this week's edition of The Lancet will shed new light on two leading causes of pneumonia, the world’s leading killer of children under age 5, both globally and within specific countries. The...

326 - Weekly Media Briefing on 2009 H1N1 Flu; Friday, September 11 at 1:00 p.m. at HHS

-(Business Wire)-September 10, 2009 - The Department of Health and Human Services will host the weekly H1N1 press briefing this Friday, September 11, in Washington, D.C. Top scientists and doctors from the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and...

327 - Quidel to Present at Investor Conferences in September

SAN DIEGO-(Business Wire)-September 10, 2009 - Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, announced today that President and Chief Executive Officer Douglas Bryant will be presenting at the CL King & Associates 7th Annual Best Ideas...

328 - Quidel Anticipates Record Quarterly Results Driven by Strong Demand for Flu Tests

SAN DIEGO-(Business Wire)-September 10, 2009 - Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care diagnostic tests, announced today that it currently anticipates its highest quarterly revenue and operating income in its history, driven by global shipments of its...

329 - Adventist Health System Signs Agreement with Dolbey to Implement Fusion CAC Powered by EMscribe, Computer-Assisted Coding Solution

CONCORD, Ohio-(Business Wire)-September 10, 2009 - Dolbey Systems, Inc. and Adventist Health System have signed an agreement to implement Fusion CAC™ Powered by EMscribe™, Dolbey’s computer-assisted coding solution. Dolbey will install Fusion CAC across the Adventist Health System’s 33...

330 - E-18 Corp. Announces Availability of a White Paper by SmallcapInsights.com

MINNEAPOLIS-(Business Wire)-September 10, 2009 - E-18 Corp. (OTCBB:ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a white paper on the global market for safety syringes...

331 - Ecolab Partners with the Joint Commission's Center for Transforming Healthcare to Improve Patient Safety

ST. PAUL, Minn.-(Business Wire)-September 10, 2009 - Ecolab Inc. announced today it is partnering with the Joint Commission’s new Center for Transforming Healthcare to support a study to improve hand hygiene. The goal of the study, which will be conducted at eight leading hospitals and health...

332 - Adamis Pharmaceuticals Pre-Filled Epinephrine Syringe Categorized as a Generic by Leading Drug Database Providers

SAN DIEGO-(Business Wire)-September 10, 2009 - Adamis Pharmaceuticals Corporation (OTCBB:ADMP) announced on July 23 that its wholly owned subsidiary, Adamis Labs launched and shipped the first orders of the company’s Epinephrine Injection, USP, 1:1000 (0.3mg prefilled single dose syringe...

333 - Inviragen Receives Additional Grant to Support Dengue Vaccine Development

FORT COLLINS, Colo. & MADISON, Wis.-(Business Wire)-September 10, 2009 - Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its continued efforts to develop a safe and effective...

334 - Oculus Innovative Sciences Receives Medicare HCPCS Code for Reimbursement of Microcyn® Skin & Wound HydroGel

PETALUMA, Calif.-(Business Wire)-September 10, 2009 - Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced today that Noridian Administrative Services LLC...

335 - Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Morgan Stanley Conference

ROCKVILLE, Md.-(Business Wire)-September 10, 2009 - Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 2009 Morgan Stanley Global Healthcare Unplugged Conference will be webcast and may be accessed at www.hgsi.com A member of Human Genome Sciences’ senior...

336 - Scarab Genomics and NeoClone Have Entered Into License Agreement for Antibodies Against Shiga Toxin

MADISON, Wis.-(Business Wire)-September 10, 2009 - Scarab Genomics, a leader in E coli technology, has entered into a license agreement with NeoClone to market and distribute their proprietary antibodies against Shiga toxin. “We are confident the research and diagnostic markets will welcome access...

337 - Influencing the Flu: How to Prevent H1N1 by Changing Kids’ Hand-Washing Behavior

PROVO, Utah-(Business Wire)-September 10, 2009 - With the White House estimating that 30 to 50 percent of Americans will contract H1N1 flu this season, you’d think more people would be focused on prevention. According to research by the New York Times bestselling authors of Influencer: The Power...

338 - QIAGEN Releases New Pandemic Influenza A/H1N1 Detection Kit

VENLO, The Netherlands & DALIAN, China-(Business Wire)-September 10, 2009 - QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), today announced both the launch of a new Influenza A/H1N1 test and several updates to its activities in providing solutions for the global surveillance of the...

339 - ChinaBio® Day Unveils Program Highlights

CARLSBAD, Calif. & SAN FRANCISCO-(Business Wire)-September 10, 2009 - EBD Group and ChinaBio® LLC, today unveiled program highlights for the ChinaBio® Day event to be held on September 15, 2009 at the San Francisco Marriott. In the heart of the American biotech industry, this unique event will...

340 - HIV Screening Tests Proposed to Be Added to Medicare’s List of Covered Preventive Services

WASHINGTON-(Business Wire)-September 9, 2009 - The Department of Health and Human Services (HHS) today announced a new proposal that would cover Human Immunodeficiency Virus (HIV) infection screening for Medicare beneficiaries who are at increased risk for the infection, including women who are...

341 - Metabasis Therapeutics Receives Notice of Delisting from Nasdaq Capital Market

SAN DIEGO-(Business Wire)-September 9, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the “Staff”) notifying the Company that it did not comply with the minimum...

342 - Vertex Pharmaceuticals Announces Webcast of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass.-(Business Wire)-September 9, 2009 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2009 at 2:45 p.m. EDT and at ThinkEquity’s 6th Annual Growth...

343 - Baxter International Inc. 2009 Investor Conference

DEERFIELD, Ill.-(Business Wire)-September 9, 2009 - Baxter International (NYSE:BAX), will host its 2009 Investor Conference on Wednesday, September 16, 2009, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is being webcast by Thomson/CCBN and can be accessed at Baxter’s Web site at...

344 - PolyMedix to Present at Rodman & Renshaw’s 11th Annual Global Healthcare Conference on September 10, 2009

RADNOR, Pa.-(Business Wire)-September 9, 2009 - PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will present at Rodman & Renshaw’s Eleventh...

345 - New Parental Notification Service Provides Instant Updates to Parents on H1N1 (Swine) Flu

COLUMBIA, Mo.-(Business Wire)-September 9, 2009 - Parents of school-aged children in every public and nonpublic school throughout Missouri will be able to receive instant updates about the H1N1 (Swine) flu as a result of a new, free service provided by the Missouri School Boards’ Association in...

346 - H.I.G. Ventures Invests $7 Million in Care Dynamix, Inc.

MIAMI-(Business Wire)-September 9, 2009 - H.I.G. Ventures, LLC, the venture capital affiliate of H.I.G. Capital, today announced its $7 million growth capital investment in Care Dynamix (d/b/a FluBusters). Care Dynamix provides nationwide preventative healthcare services, including vaccination...

347 - HHS Announces Availability of Congressional Flu Public Service Announcements Dealing with Seasonal or 2009 H1N1 Influenza

WASHINGTON-(Business Wire)-September 9, 2009 - Today, the U.S. Department of Health and Human Services is announcing the availability of flu public service announcements recorded by 48 members of Congress. The PSAs deliver the message that there are simple steps every American can take to reduce the...

348 - General Data’s E.V-Trax™ Vaccination Tracking System Simplifies Immunization Management and Prepares Hospitals Against H1N1 and Influenza Outbreaks

CINCINNATI-(Business Wire)-September 9, 2009 - General Data Company, Inc. , such as PeopleSoft®. General Data’s E.V-Trax system eliminates the more common paper process and manual data entry, and provides accurate, updated and timely information on individual employee vaccinations, in addition to...

349 - St. Vincent’s, State Health Department Unveil Novel Technology to Fight Spread of HIV

NEW YORK-(Business Wire)-September 9, 2009 - Saint Vincent Catholic Medical Centers and the New York State Department of Health (DOH) today unveiled a novel Web-based technology to rapidly instruct health care providers throughout New York State about HIV diagnosis and prevention. Developed by a...

350 - Research and Markets: Non-Hodgkin Lymphoma Therapy Area Pipeline Report

DUBLIN-(Business Wire)-September 9, 2009 - Research and Markets has announced the addition of the "Non-Hodgkin Lymphoma Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Non-Hodgkin Lymphoma Therapy Area Pipeline Report contains detailed information on the non-hodgkin...

351 - Over One Third of All Oral and Throat Cancers Are Due to Sexual Practices

BEVERLY HILLS, Calif.-(Business Wire)-September 9, 2009 - Infection by the human papilloma virus (HPV), the most common sexually transmitted disease, has been linked to more than one third of all oral and throat cancers according to Dr. Solomon Hamburg, president of the prestigious Tower Cancer...

352 - New, Expanded Laboratory and Manufacturing Capabilities Part of Aushon’s Corporate Headquarters Renovation

BILLERICA, Mass.-(Business Wire)-September 9, 2009 - Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA...

353 - New Promega Maxwell® 16 Viral Kit Performs Viral Purification for Labs in Mexico

MADISON, Wis.-(Business Wire)-September 9, 2009 - Promega announces the release of the Maxwell® 16 Viral Total Nucleic Acid Purification Kit which, among other labs, currently serves the OCA Hospital in Mexico for H1N1 clinical research. OCA, the largest private hospital in Monterrey Mexico...

354 - Research and Markets: Herpes Simplex Virus Infection Therapy Area Pipeline Report

DUBLIN-(Business Wire)-September 9, 2009 - Research and Markets has announced the addition of the "Herpes Simplex Virus Infection Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Herpes Simplex Virus Infection Therapy Area Pipeline Report contains detailed...

355 - HHS To Host an H1N1 Webcast to Discuss Preparedness for Parents and Child Care Providers with a Special Emphasis on Caring for Those with Medical Conditions

-(Business Wire)-September 9, 2009 - The U.S. Department of Health and Human Services (HHS) will host a Webcast for parents and child care providers to discuss what they can do to help keep themselves and their children healthy this flu season, especially those with special medical conditions that...

356 - Humco® Increases Production of Cherry Syrup for Emergency Compounding of Oral Suspension of Tamiflu® Capsules

TEXARKANA, Texas-(Business Wire)-September 9, 2009 - Responding to widespread domestic and international requests generated by anticipated increased demand for Tamiflu® during this flu season, Humco Holding Group, Inc., based here, is increasing inventories and production capabilities of Humco...

357 - Cempra Pharmaceuticals Initiates Phase 2/3 Clinical Study for an Oral Antibiotic to Treat Acute Bacterial Skin Structure Infections

CHAPEL HILL, N.C.-(Business Wire)-September 9, 2009 - Cempra Pharmaceuticals today announced that enrollment is underway in an adaptive design Phase 2/3 clinical study with CEM-102 for patients suffering from acute bacterial skin structure infections (ABSSI). CEM-102 is an oral antibiotic with an...

358 - Strategic Diagnostics Inc. and DuPont Qualicon Expand Global Distribution Agreement

NEWARK, Del. & WILMINGTON, Del.-(Business Wire)-September 9, 2009 - SDI (Strategic Diagnostics Inc., NASDAQ:SDIX), a leading provider of biotechnology-based detection solutions for food safety and life science applications, and Wilmington, DE-based, DuPont Qualicon today announced the...

359 - Burst Media Research Reveals High H1N1 Concern– Particularly Among Parents

BURLINGTON, Mass.-(Business Wire)-September 9, 2009 - Burst Media, (www.BurstMedia.com), a leading provider of advertising representation, services and technology to independent Web Publishers, today released the results of a survey on public concern about the H1N1 virus. The online survey...

360 - Leading U.S. Epilepsy Organizations Unite on H1N1 Virus “Swine Flu” Public Health Recommendations for Children with Epilepsy

WEST HARTFORD, Conn. & CHICAGO & WASHINGTON & MIDDLEBURG, Va. & BOSTON & NEW YORK-(Business Wire)-September 9, 2009 - AES, CURE, Epilepsy Foundation, Epilepsy Therapy Project and FACES today announced their support for increased public awareness of H1N1 Virus (“Swine Flu...

361 - Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers

MOUNTAIN VIEW, Calif.-(Business Wire)-September 9, 2009 - Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009. Considering that fewer than 20 genomes have been...

362 - ParaPRO Launches MyHeadLiceTreatment.com – A Comprehensive Head Lice Web Portal

CARMEL, Ind.-(Business Wire)-September 9, 2009 - Just in time for peak head lice season, ParaPRO, LLC has launched MyHeadLiceTreatment.com, a free, engaging and comprehensive “one-stop shop” about head lice. Treating head lice can be an issue. The U.S. Centers for Disease Control and...

363 - NIH Issues $2.87 Million Grant for Development of Ceragenin™ Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections

DENVER-(Business Wire)-September 9, 2009 - Ceragenix Pharmaceuticals, Inc. (“Ceragenix”) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health (“NIH”) has awarded a $2.87 million grant to fund the pre...

364 - Walgreens Pharmacies and Take Care Clinics Now Offering Seasonal Flu Shots Daily from 10 A.M. - 4 P.M.

DEERFIELD, Ill.-(Business Wire)-September 8, 2009 - From the President of the United States to local health officials, authorities throughout the country are encouraging people to be proactive when it comes to flu prevention this year, starting with getting a seasonal flu shot. Walgreens (NYSE...

365 - Research and Markets: The German Blood Banking Market through 2013

DUBLIN-(Business Wire)-September 8, 2009 - Research and Markets has announced the addition of the "The German Blood Banking Market through 2013" report to their offering. This report presents a comprehensive analysis of the German blood banking market, including: Major issues pertaining to the...

366 - Amerinet Named Provider of Choice by National Rural Health Association Partnership

ST. LOUIS-(Business Wire)-September 8, 2009 - In recognition of their commitment to helping rural healthcare providers reduce costs and improve quality, Amerinet, a leading national healthcare group purchasing organization, has been named a “Provider of Choice” by the National Rural Health...

367 - Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs

NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Mohan Chellani, Ph.D., formerly a senior manager with Quest Diagnostics, as Vice President of Scientific Affairs at its Enzo Clinical Labs subsidiary. He will oversee all aspects of the...

368 - Reportlinker Adds The Global Influenza Market - 2009 Edition

NEW YORK-(Business Wire)-September 8, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds The Global Influenza Market - 2009 Edition...

369 - Biomagnetics Diagnostics Corp. to Enter Integrated Optical Biosensor System (IOBS) Market

ORANGEVALE, Calif.-(Business Wire)-September 8, 2009 - Biomagnetics Diagnostics Corp. (Pink Sheets: BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced its entry into the Integrated Optical Biosensor System...

370 - Response Biomedical to Present at Rodman & Renshaw Annual Global Investment Conference

VANCOUVER, British Columbia-(Business Wire)-September 8, 2009 - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that S. Wayne Kay, Chief Executive Officer, will present a corporate update at the Rodman & Renshaw 11th Annual Healthcare Conference as part of Rodman and...

371 - Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference

NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE: ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David...

372 - Opexa to Present at the Rodman & Renshaw 11th Annual Healthcare Conference September 11, 2009

THE WOODLANDS, Texas-(Business Wire)-September 8, 2009 - Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s president and chief executive officer, will deliver a...

373 - Research and Markets: An Essential Malaria Therapy Area Pipeline Report

DUBLIN-(Business Wire)-September 8, 2009 - Research and Markets has announced the addition of the "Malaria Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Malaria Therapy Area Pipeline Report contains detailed information on the malaria drug pipeline. This report...

374 - FDA and BioTrove Collaborate to Evaluate BioTrove’s Novel Genetic Profiling and Pathogen Detection System for Possible Use in Detecting Threats to the Nation’s Blood Supply

WOBURN, Mass.-(Business Wire)-September 8, 2009 - BioTrove announced a collaboration with the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research to investigate the utility of the company’s Standardized NanoArray PCR (SNAP) gene expression profiling system for the...

375 - Secretary Sebelius to Join Philadelphia Students for “Back to School” Event

-(Business Wire)-September 5, 2009 - U.S. Secretary of Health and Human Services Kathleen Sebelius will travel to Philadelphia, Pa. on Tuesday, September 8th as part of President Obama’s “We Are What We Learn” initiative. Sebelius will meet with 7th grade students and parents from the Thurgood...

376 - ETBOND TECHNOLOGYTM Defines Biotechnology Approach for Global Healthcare Reform

BROOKLYN, N.Y.-(Business Wire)-September 5, 2009 - ETBOND TECHNOLOGY defines Biotechnology approach to fight H1N1 Influenza A (Swine Flu) 1. Plan for Morbidity Reduction: H1N1 Influenza A (Swine Flu and its symptoms) is spreading at a lightening speed globally. It is infecting millions of patients...

377 - Upp Technology enhances irms|PM (Patient Management) for Fall Distribution of H1N1 Vaccines

DOWNERS GROVE, Ill.-(Business Wire)-September 4, 2009 - Today, Upp Technology, a leading provider of public health solutions, announced the new enhanced version of their irms|PM (Patient Management) software product. The new version offers greater flexibility and faster patient processing creating a...

378 - Emergent BioSolutions to Webcast Presentation at Upcoming Investor Conference

ROCKVILLE, Md.-(Business Wire)-September 4, 2009 - Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the following investor conference during the month of September 2009. The 11th Annual Rodman & Renshaw Healthcare ConferenceNew...

379 - Sebelius, Duncan and Dr. Beth Bell from the Centers for Disease Control and Prevention to Discuss New Flu Guidance Issued to Childcare Facilities

-(Business Wire)-September 3, 2009 - U.S. Secretary of Health and Human Services Kathleen Sebelius, U.S. Education Secretary Arne Duncan, and Dr. Beth Bell, Centers for Disease Control and Prevention (CDC), will hold a conference call with reporters to discuss guidance issued to childcare facilities...

380 - H1N1 Vaccine for Statewide Distribution Streamlined by Upp Technology

DOWNERS GROVE, Ill.-(Business Wire)-September 3, 2009 - Based on feedback from their national client base of Public Health Agencies and First Responders, Upp Technology has added significant enhancements to its already award winning irms|EM (Emergency Management) software. The new irms|EM product...

381 - Vertex Pharmaceuticals Announces Webcast of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass.-(Business Wire)-September 3, 2009 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the Thomas Weisel Partners 2009 Healthcare Conference on Wednesday, September 9, 2009 at 2:40 p.m. EDT and at the Baird 2009 Health Care...

382 - IAVI: Two New Antibodies Found to Cripple HIV

NEW YORK & LA JOLLA & SAN FRANCISCO, Calif. & SEATTLE-(Business Wire)-September 3, 2009 - Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences and Monogram...

383 - New Promega GoTaq® qPCR Master Mix Excels in Sensitivity and Stability

MADISON, Wis.-(Business Wire)-September 3, 2009 - Now real-time PCR methods can detect even smaller changes and rare events with the new Promega GoTaq qPCR Master Mix. The new GoTaq qPCR Master Mix frequently delivers earlier cycle thresholds than SYBR® Green I. The advanced functionality gives...

384 - Bio-Bridge Science to Present at Rodman & Renshaw 11th Annual Healthcare Conference on September 11

OAK BROOK, Ill.-(Business Wire)-September 3, 2009 - Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company focused on the commercial development of biological products for the prevention and treatment of human diseases, and production materials used in producing vaccines, announced today...

385 - Illumina to Present at Upcoming Investment Conferences in September

SAN DIEGO-(Business Wire)-September 3, 2009 - Illumina, Inc. (NASDAQ:ILMN) today announced that the Company will webcast its presentations at three upcoming investment conferences. Illumina will webcast its presentation at the Thomas Weisel Partners Healthcare Conference in Boston, Massachusetts...

386 - Helicos BioSciences Provides Q2 2009 Operating Highlights and Strategic Update

CAMBRIDGE, Mass.-(Business Wire)-September 3, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30...

387 - Metabasis Hires Financial Advisor to Evaluate Strategic Alternatives

SAN DIEGO-(Business Wire)-September 3, 2009 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that it has hired Merriman Curhan Ford as its financial advisor to assist the Company in exploring and evaluating strategic alternatives. At this time, Metabasis has not made a decision to pursue...

388 - Enabling Capabilities of Inovio Biomedical’s Electroporation Delivery Technology with SIV DNA Vaccine Confirmed in Collaborative Study With National Cancer Institute

SAN DIEGO-(Business Wire)-September 3, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that data generated from a pre-clinical collaborative study by National Cancer Institute (NCI) and Inovio scientists were published...

389 - California Pharmacists Partner with FEMA to Promote National Preparedness Month During Sixth Annual National Preparedness Month

SACRAMENTO, Calif.-(Business Wire)-September 2, 2009 - As a proud member of FEMA’s National Preparedness Month Coalition, the California Pharmacists Association is helping to coordinate efforts of pharmacies throughout the state in promoting the Ready America message to: get a kit, make a plan, be...

390 - SDI Reports: Number of Flu Vaccines Given in Physicians’ Offices Up 237% So Far This Season

PLYMOUTH MEETING, Pa.-(Business Wire)-September 2, 2009 - According to SDI, a leading healthcare market insight and analytics firm that consolidates electronic healthcare claims data, there have been over 477,000 seasonal flu vaccinations already administered through Aug. 29 — the fourth week of...

391 - Medtronic Initiates Phase II Hepatitis C Clinical Study ''COPE-HCV'' to Determine Tolerability and Safety of Continuous Interferon Infusion for Patients with HCV

MINNEAPOLIS-(Business Wire)-September 2, 2009 - Medtronic, Inc. (NYSE: MDT), today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company’s first-ever...

392 - Tennessee Department of Health Extends Contract with Upp Technology, Inc.

DOWNERS GROVE, Ill.-(Business Wire)-September 2, 2009 - Upp Technology will provide a centralized emergency management solution to the Tennessee Department of Health that will improve the availability of patient information and the efficiency of an emergency response. Already utilizing Upp’s...

393 - Oculus Innovative Sciences’ Stock Options Now Trading on NYSE Arca Options

PETALUMA, Calif.-(Business Wire)-September 2, 2009 - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to treat infections in chronic and acute...

394 - TheraDoc Forms Infection Prevention and Control Clinical Advisory Board

SALT LAKE CITY-(Business Wire)-September 2, 2009 - TheraDoc, a clinical informatics pioneer that has been helping hospitals leverage information technology to improve patient care for more than 10 years, today announced the formation of an Infection Prevention and Control Clinical Advisory Board...

395 - Broadcast Quality H1N1 Flu PSAs Featuring Elmo Available for Download

WASHINGTON-(Business Wire)-September 1, 2009 - The Department of Health and Human Services, the Department of Homeland Security, the Department of Education and Sesame Workshop, the nonprofit educational organization behind Sesame Street, have teamed up to launch a new, national public service...

396 - PURE Bioscience to Raise $3 Million in Registered Direct Financing

SAN DIEGO-(Business Wire)-September 1, 2009 - PURE Bioscience (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has received commitments from institutional investors to purchase $3 million of securities in a registered direct offering...

397 - Alpha Pro Tech, Ltd. Announces Increased Production of N-95 Respirator Masks for Upcoming Flu/Swine Flu Season

SALT LAKE CITY-(Business Wire)-September 1, 2009 - Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced that it will be tripling the average...

398 - Mosquitoes Don’t “Fall” Away as a Major Pest Problem When Summer Ends

FAIRFAX, Va.-(Business Wire)-September 1, 2009 - As summer begins to fade, the National Pest Management Association (NPMA) reminds homeowners of the ongoing caution necessary when dealing with increased mosquito populations across the United States. Although the itchy welts of mosquitoes are...

399 - SUPERVALU PHARMACIES Expands Flu Shot Program

FRANKLIN PARK, Ill.-(Business Wire)-September 1, 2009 - With an eye on convenience, cost and consumer education, SUPERVALU PHARMACIES this year has expanded its traditional flu shot offering to help ease some of the anxieties the upcoming flu season may bring. Like in seasons past, specially trained...

400 - PURE Bioscience Forms Advisory Panel

SAN DIEGO-(Business Wire)-September 1, 2009 - PURE Bioscience (NASDAQ:PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the inaugural members of its newly formed Advisory Panel: Tom Ridge, first Secretary of the U.S. Department of Homeland Security and...

Search Our News Using Google Search

Can't find what you want? Try using Google:

	Enter your search terms Submit search form
	Web www.digital50.com

	Subscribe to our RSS feeds and get press releases delivered daily
	Subscribe to Business Press Releases in up to 210 Industries
	Add the DiGiTAL50 Search to your Site, FREE!